<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>
NAS:CERS (USA) Also Trade In: Germany

Cerus Corp $ 4.52 0.22 (5.12%)

Volume:
834,099
Avg Vol (1m):
863,118
Market Cap $:
632.84 Mil
Enterprise Value $:
600.89 Mil
P/E (TTM):
0.00
P/B:
9.50
Warning! GuruFocus has detected 1 Severe warning sign with CERS. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

CERS News and Headlines - Cerusrp

GuruFocus Articles Total 12
  • 1

NEW YORK, April 10, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Fortive Corporation (:FTV), Pieris Pharmaceuticals, Inc. (PIRS), CEVA, Inc. (CEVA), ManTech International Corporation (MANT), Cerus Corporation (CERS), and NN, Inc. (NNBR), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

FTV DOWNLOAD:

0 Views    Marketwired    2019-04-10 12:00

NEW YORK, Oct. 18, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Cerus Corporation (CERS), AdvanSix Inc. (:ASIX), Spark Therapeutics, Inc. (ONCE), Imperva, Inc. (IMPV), Central Garden & Pet Company (CENTA), and Francesca's Holdings Corporation (FRAN), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

0 Views    Marketwired    2018-10-18 16:00

NEW YORK, Aug. 28, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Evertec, Inc. (:EVTC), Cerus Corporation (CERS), REV Group, Inc. (:REVG), U.S. Silica Holdings, Inc. (:SLCA), The Manitowoc Company, Inc. (:MTW), and World Fuel Services Corporation (:INT), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the

0 Views    Marketwired    2018-08-28 16:00

NEW YORK, June 28, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Torchmark Corporation (:TMK), Cerus Corporation (CERS), American Equity Investment Life Holding Company (:AEL), Southern Copper Corporation (:SCCO), F5 Networks, Inc. (FFIV), and Diebold Nixdorf, Incorporated (:DBD), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the

0 Views    Marketwired    2018-06-28 16:00

NEW YORK, May 15, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Cerus Corporation (CERS), Health Insurance Innovations, Inc. (HIIQ), Tetra Tech, Inc. (TTEK), Ferro Corporation (:FOE), Dril-Quip, Inc. (:DRQ), and MSC Industrial Direct Company, Inc. (:MSM), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

0 Views    Marketwired    2018-05-15 16:01
The guru increased his position in the last 2 quarters

Ron Baron (Trades, Portfolio) founded Baron Capital Management, an investment management firm. In both the first and second quarters, the guru invested in the following stocks:

Adamas Pharmaceuticals Inc. (ADMS)

In the first quarter, Baron increased his position by 81.87% and by 45.50% in the second quarter.

a7f08fc7e3669192558b07c9f768dc9d.png

The pharmaceutical company has a market cap of $479.33 million. Its revenue fell 90% over the last 12 months, but the stock price has risen 34% over the last several weeks.

Steven Cohen (Trades, Portfolio) is the company's largest shareholder among the

242 Views    Tiziano Frateschi    2017-09-07 20:56
Guru stock highlight

Cerus Corporation (NASDAQ:CERS) has an FDA and EU approved device that inactivates pathogens such as viruses and bacteria in donated blood. Current regulatory approvals cover use of the Cerus device for platelets and plasma from donated blood (an $800 million worldwide, and $350 million U.S. market opportunity, for which Cerus has signed up over 80% of all U.S. blood centers). If additional approvals for usage with red blood cell (RBC) components are obtained, Cerus will add an estimated $2.5 billion in market opportunity ($1 billion in the U.S., in the same blood centers), for which there is no current

150 Views    Holly LaFon    2017-01-20 21:18
Guru stock highlight

Cerus Corporation (CERS) is a leading provider of medical equipment to the blood banking industry. Its equipment performs pathogen inactivation (PI) on donated blood, preventing infections via transfused blood caused by viruses and bacteria in donated units. Cerus gained significantly in the fourth quarter as it started to gain contracts with a significant number of U.S. blood centers for PI in platelets and plasma. We believe that Cerus has what is likely to be an insurmountable lead in the U.S., and market leading E.U. position for its products. We should see substantial growth for years to come as we expect

514 Views    Holly LaFon    2016-02-25 21:35

Cerus Corp. (CERS) filed Annual Report for the period ended 2010-12-31. Cerus Corp. has a market cap of $119.2 million; its shares were traded at around $2.52 with and P/S ratio of 5.1. Cerus Corp. had an annual average earning growth of 1.6% over the past 5 years.



Highlight of Business Operations:

In June 2005, we and Baxter entered into a definitive agreement with BioOne for commercialization of our plasma system in specified parts of Asia. Under the terms of the 2005 agreement, BioOne was responsible for seeking regulatory approvals for and commercializing the plasma system in Japan, China, Taiwan, South

855 Views    gurufocus    2011-03-16 21:34

Cerus Corp. (CERS) filed Quarterly Report for the period ended 2010-06-30. Cerus Corp. has a market cap of $111.25 million; its shares were traded at around $2.86 with and P/S ratio of 6.19. Cerus Corp. had an annual average earning growth of 1.6% over the past 5 years.

CERS is in the portfolios of [url=http://www.gurufocus.com/StockBuy.php?GuruName=Chuck+Royce]Chuck Royce[/url] of Royce& Associates.

Highlight of Business Operations:

Revenue from government grants and cooperative agreements decreased $0.1 million to $0.2 million for the three months ended June 30, 2010, from $0.3 million for the comparable period in 2009. The decrease was due primarily to a decrease

736 Views    gurufocus    2010-08-16 11:14

Cerus Corp. (CERS) filed Quarterly Report for the period ended 2010-03-31. Cerus Corp. has a market cap of $115.6 million; its shares were traded at around $2.98 with and P/S ratio of 6.4.

CERS is in the portfolios of [url=http://www.gurufocus.com/StockBuy.php?GuruName=Chuck+Royce]Chuck Royce[/url] of Royce& Associates.

Highlight of Business Operations:

Product revenue increased $2.4 million to $5.5 million during the three months ended March 31, 2010, compared to $3.1 million during the comparable period in the prior year. The increase in product revenue was primarily a result of an increase in disposable kit sales to customers, and also impacted by an increase

820 Views    gurufocus    2010-05-12 20:16

Cerus Corp. (CERS) filed Quarterly Report for the period ended 2009-09-30. Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology including pathogen inactivation of source plasma used for fractionation improving the outcomes of stem cell transplantation. Cerus Corp. has a market cap of $72.7 million; its shares were traded at around $1.88

759 Views    gurufocus    2009-11-06 22:24

Headlines Total 43
  • 1

2019-08-14 $ 5.22 (-2.06%)
5:01pm
2019-08-01 $ 5.85 (%)
9:51pm
5:35pm
2019-07-25 $ 5.69 (-2.57%)
9:34am
2019-05-07 $ 6.57 (0.61%)
10:33pm
8:23pm
6:25pm
2019-04-30 $ 6.13 (0.49%)
9:32am
2019-02-26 $ 6.3 (-2.02%)
11:08pm
2019-01-30 $ 5.72 (0.53%)
9:45am
2018-11-01 $ 6.77 (1.04%)
7:03pm
2018-10-18 $ 6.77 (1.2%)
11:00am
2018-09-27 $ 7.27 (0.14%)
10:08am
2018-08-06 $ 7.14 (1.56%)
6:30am
2018-08-02 $ 7.41 (-0.8%)
10:33pm
5:20pm
2018-07-30 $ 7.18 (-1.91%)
6:26am
2018-07-27 $ 7.32 (-4.44%)
7:41am
2018-05-15 $ 6.45 (-1.98%)
11:01am
2018-05-09 $ 6.29 (14.99%)
1:45pm
2018-03-24
11:13pm
2018-03-19 $ 5.47 (-4.7%)
7:36am
2018-03-18
12:49pm
2018-03-14 $ 5.42 (5.65%)
6:23pm
2018-02-27 $ 4.25 (-0.93%)
8:44am
2018-01-25 $ 4.94 (-1.4%)
8:00am
2018-01-24 $ 5.01 (15.7%)
2:46pm
12:34pm
2017-12-27 $ 3.41 (-2.85%)
8:49am
2017-12-11 $ 3.62 (-0.55%)
7:00am
2017-11-15 $ 3.63 (3.42%)
8:38am
2017-11-14 $ 3.51 (-1.96%)
8:16am
2017-11-03 $ 3.52 (22.22%)
1:31pm
2017-10-05 $ 3.05 (8.16%)
6:09pm
2017-09-28 $ 2.73 (0.37%)
1:58pm
2017-09-11 $ 2.69 (0.37%)
1:13pm
2017-08-22 $ 2.48 (%)
9:53am
2017-01-20 $ 4.39 (1.86%)
3:18pm
2016-02-25 $ 4.98 (-2.35%)
3:35pm
2011-03-16 $ 2.47 (-1.98%)
4:34pm
2010-08-16 $ 2.98 (4.2%)
6:14am
2010-05-12 $ 3.06 (2.68%)
3:16pm
2009-11-06 $ 1.94 (3.19%)
4:24pm
Total 43
  • 1